Effects of Probiotics on Respiratory Tract Infections and Quality of Life in Children: A Large, Prospective,

Yali Zhang1, Xiaohui Li2, Jie Yuan2

  • 1School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.

Insights

This study found that probiotics significantly reduced respiratory infections in children, improving their health and well-being in real-world settings. Caregivers reported fewer symptoms and medical visits, supporting probiotic use as a preventive strategy.

Area of Science:

  • Pediatric Health
  • Microbiome Research
  • Immunology

Background:

  • Respiratory tract infections (RTIs) are a significant burden in children's healthcare.
  • While randomized controlled trials (RCTs) suggest probiotic benefits, real-world evidence from community settings is limited.

Purpose of the Study:

  • To evaluate the impact of combined Lactobacillus rhamnosus CRL1505 and Bifidobacterium breve M-16V on respiratory and general health in children.
  • To assess the effectiveness of probiotics in a large, community-based pediatric population.

Main Methods:

  • A prospective, multicenter, single-arm, community-based study involving 236 children aged 0-14 years with recent RTIs.
  • Children received a 4-week course of probiotics; outcomes included symptom frequency, medical visits, and quality of life (QoL) via questionnaires.

Main Results:

  • Probiotic use was associated with significant reductions in cold frequency (95.34%) and medical visits (94.49%).
  • Marked improvement or complete symptom disappearance was observed in 80.51% of children, with symptom relief within 1-3 days for 58.47%.
  • Quality of life improved in 97.88% of children, with notable gains in appetite, energy, and sleep.

Conclusions:

  • Probiotic supplementation demonstrated a reduction in RTI burden and enhanced daily well-being in a real-world pediatric cohort.
  • These findings support the use of probiotics as a preventive strategy in community settings, complementing existing RCT data.
Abstract

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...